SHILPAMED.NSSHILPAMED.NSNSE
Loading
R&D Expenses Over TimeExpanding
Percentile Rank86
3Y CAGR-4.2%
5Y CAGR+5.6%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-4.2%/yr
vs +19.2%/yr prior
5Y CAGR
+5.6%/yr
Recent deceleration
Acceleration
-23.4pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$483.73M+56.3%
2024$309.56M-37.0%
2023$491.02M-10.8%
2022$550.61M+62.9%
2021$338.09M-8.4%
2020$368.99M+73.2%
2019$213.04M-21.9%
2018$272.77M+13.3%
2017$240.77M-21.3%
2016$305.78M-